November 3, 2026 Type 1 diabetes briefing: trials, device safety, and research signals
A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.
Read today's brief
Source-backed article
- openFDA device recallsTandem Diabetes Care, Inc.: Tandem Mobi Insulin Pump, Models: 1004004, 1010750, 1012676, 1012719, 1013655, 1013656, 1013501, 1013700, 1014081, 1014801, 1014811, 1014813, 1014936, 1016911, 1016912, 1016913, 1...
- openFDA device recallsMedtronic MiniMed, Inc.: Generic Name: MiniMed Go App Generic Name: MiniMed Go App Model/Catalog Number: MMT-8600 (iOS), MMT-8601 (Android) Software Version: Software version 1.2.1 Product Description: Th...
- ClinicalTrials.govA Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- ClinicalTrials.govSAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- ClinicalTrials.govThink-Find-Solve Activities for Insulin Self-Management in Type 1 Diabetes


















































































































































































